Emerging Technologies | Neuroscience
Neuroimaging is a field of medicine that deals with the diagnosis and treatment of neurological disorders. Neuroimaging includes the use of various imaging modalities such as computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and single-photon emission computed tomography (SPECT).
Some of the emerging trends in neuroimaging include the use of functional magnetic resonance imaging (fMRI) to study brain activity, the use of diffusion tensor imaging (DTI) to study the structure of the brain, and the use of positron emission tomography (PET) to study the function of the brain.
See live data on companies, R&D, markets, and news
In order to access the link, you need a Mergeflow account.
Frequently asked questions about the trial
How does the trial work?
After you sign up, you'll receive an email from us with an account activation link. Over the course of the trial, we'll send you emails with tips and tricks. The trial ends automatically after 14 days. No further obligations on your part.
Does the trial include all features?
The trial includes all Analyst Plan features.
Will I be charged when my trial is up?
No. We do not ask for your credit card up front, so you will only be charged when you decide to buy a subscription.
Do I have to install anything?
No. Mergeflow is a SaaS software that runs in any modern web browser. And because it's a subscription, you get constant product updates.
Which payment options does Mergeflow offer?
You can pay your Innovator or Analyst subscription via credit card (American Express, MasterCard, Visa) or SEPA Direct Debits. The larger team plans, API and enterprise solutions can be paid via invoicing and bank transfer.
Does Mergeflow keep my data private?
Yes. We don't serve ads, we never sell anything you give us, and we protect your privacy.